Pens
Explore FatPig Peptides’ range of precision-formatted research pens, supplied exclusively for laboratory and analytical research.
All products within this category are strictly for research purposes only. They are not medicines and must not be used for human or veterinary consumption or administration.
FatPig Retatrutide 40 mg Research Pen
£200
Retatrutide is a synthetic investigational peptide currently being studied for its activity at the GIP, GLP-1 and glucagon receptors. The FatPig Retatrutide Research Pen contains a declared total peptide mass of 40 mg in a convenient research format.
This product is supplied exclusively for controlled laboratory, analytical and scientific research.
Important: “40 mg” describes the total declared peptide mass contained within the pen. It is not a recommended dose, administration instruction or treatment schedule.
Product information
- Compound: Retatrutide
- Research identifier: LY3437943
- Format: Research pen
- Declared peptide content: 40 mg total
- Classification: Investigational research peptide
- Intended use: Laboratory and analytical research only
- Human or veterinary use: Strictly prohibited
- Regulatory status: Not a licensed or approved medicine
Delivery
Orders are dispatched using a Royal Mail tracked service. Tracking information will be provided once your order has been dispatched.
Estimated delivery is normally within 24–48 hours following dispatch, although delivery times cannot be guaranteed.
About Retatrutide
Retatrutide is an engineered peptide being investigated as a triple receptor agonist. In controlled clinical research, it has been studied for its interaction with:
- Glucose-dependent insulinotropic polypeptide receptors (GIPR)
- Glucagon-like peptide-1 receptors (GLP-1R)
- Glucagon receptors (GCGR)
These signalling pathways are associated with metabolic and endocrine regulation. Retatrutide remains investigational and has not been approved for general medical use.
What does “40 mg” mean?
The 40 mg specification refers to the declared total mass of retatrutide contained within the complete research pen.
It does not indicate:
- A single or recommended dose
- A frequency or treatment schedule
- A method of administration
- Suitability for human use
- The final concentration without reference to the complete product specification
The milligram value is provided solely as a quantitative product and inventory specification.
Frequently asked questions
What is FatPig Retatrutide 40 mg?
It is a research product containing a declared total peptide mass of 40 mg retatrutide in a pen format. It is supplied strictly for laboratory and analytical research.
Is FatPig Retatrutide the same as Synedica Retatrutide?
Retatrutide is the underlying compound. “FatPig” and “Synedica” are supplier or product identifiers and do not represent different internationally recognised names for the peptide.
Is Retatrutide an approved medicine?
No. Retatrutide remains an investigational compound and is not currently a licensed medicine for general use.
Can this product be used on humans or animals?
No. FatPig Retatrutide is supplied strictly for laboratory research and must not be consumed or administered to humans or animals.
Does the pen format provide usage instructions?
No. The format and 40 mg specification are product descriptors only. FatPig Peptides does not provide medical, dosing or administration advice.
Research Use Only: Not for human or veterinary consumption or administration. Not a medicine, supplement or cosmetic product. Buyers are responsible for ensuring that purchase, possession and use comply with all applicable regulations.
